Latest medical research, clinical studies, and health discoveries
NIH researchers discovered DFNZ, a synthetic opioid that relieves severe pain without addiction, dependency, or withdrawal — a potential breakthrough.
Scientists Find a Powerful Pain Reliever With No Addiction Risk Read More »
NIH-funded researchers engineered a miniaturized CRISPR enzyme that fits inside viral delivery vehicles, achieving 80%+ editing efficiency for cancer and ALS targets.
CRISPR Gets Smaller — and More Powerful Against Cancer and ALS Read More »
New research links vitamin D levels to type 2 diabetes risk. Learn what major studies reveal about supplements, genetic factors, and blood sugar.
Vitamin D and Diabetes Prevention: What the Research Shows Read More »
A 2026 Nature Medicine study links the herbicide picloram to early-onset colorectal cancer. What researchers found and what it means for prevention.
Pesticide Linked to Rising Colorectal Cancer in Young Adults Read More »
A new $20 blood test called MethylScan detects liver, lung, ovarian, and stomach cancers with 98% specificity. Here is what the latest research shows.
One Blood Test Could Soon Screen for Four Cancers at Once Read More »
Insulin resistance affects millions silently. Learn the warning signs, causes, and evidence-based strategies to restore metabolic health.
Insulin Resistance: The Silent Driver of Chronic Disease Read More »
GLP-1 drugs like Ozempic and Wegovy can cause significant muscle loss. Learn what 2026 research shows and how to protect your lean mass.
GLP-1 Drugs and Muscle Loss: What You Need to Know Read More »
Research links anemia to higher dementia risk. Learn how low hemoglobin affects your brain and what steps may help protect cognitive health.
Anemia and Dementia Risk: What the Research Shows Read More »
Scientists found GLP-1—the hormone behind Ozempic—naturally in joint fluid. Here’s what this Lancet Rheumatology study means for arthritis.
GLP-1 Found in Joints: New Clues for Arthritis Treatment Read More »
NIH discovers DFNZ, a synthetic painkiller that targets opioid receptors without addiction or overdose risk — a potential breakthrough in pain medicine.
A Non-Addictive Painkiller? NIH’s DFNZ Discovery Explained Read More »
